Polymorphisms of interleukin-4--related genes in Japanese children with minimal change nephrotic syndrome

Am J Kidney Dis. 2003 Aug;42(2):271-6. doi: 10.1016/s0272-6386(03)00652-8.

Abstract

Background: Minimal change nephrotic syndrome (MCNS) in children frequently is associated with allergy and immunoglobulin E production. T Helper subtype 2 cytokines, such as interleukin-4 (IL-4), may have an important role in the development of atopy. We investigated the associations of gene polymorphisms of IL-4, its receptor (IL-4R), and the signal transducer and activator 6 (STAT6) gene with MCNS.

Methods: We analyzed these polymorphisms in Japanese children with MCNS (n = 58) and healthy controls with neither allergic nor renal disease (n = 63). The polymerase chain reaction (PCR) and restriction fragment length polymorphism method was used for the IL-4 promoter gene polymorphism (-590C/T), and PCR single-strand conformation polymorphism analysis was used for the IL-4Ralpha chain gene (1902A/G) and STAT6 3' untranslated region (2964G/A) polymorphisms.

Results: There was a significant difference between the MCNS group and controls in genotypic distribution of IL-4 promoter gene polymorphism. Frequency of the T allele was significantly lower in the MCNS group than controls. There was no difference between the MCNS group and controls in the IL-4R gene polymorphism. In the STAT6 gene, no significant differences in genotypic and allelic distribution were observed between the 2 groups. However, there were significant differences between patients who did not need cytotoxic agents or who experienced 3 or fewer relapses and controls.

Conclusion: These results suggest that genetic variations in the IL-4 and STAT6 genes may be associated with predisposition to MCNS, partially the clinical course of MCNS.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Disease Progression
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Hypersensitivity / genetics
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Interleukin-4 / genetics*
  • Japan / epidemiology
  • Male
  • Nephrosis, Lipoid / drug therapy
  • Nephrosis, Lipoid / ethnology
  • Nephrosis, Lipoid / genetics*
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / ethnology
  • Nephrotic Syndrome / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single-Stranded Conformational
  • Promoter Regions, Genetic
  • Receptors, Interleukin-4 / genetics*
  • Recurrence
  • STAT6 Transcription Factor
  • Trans-Activators / genetics*

Substances

  • Immunosuppressive Agents
  • Receptors, Interleukin-4
  • STAT6 Transcription Factor
  • STAT6 protein, human
  • Trans-Activators
  • Interleukin-4